• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜铬粒蛋白 A 和突触素在胰腺神经内分泌肿瘤中的意义。

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors.

机构信息

Departments of Integrative Biosciences and Pathology, Oregon Health and Science University, Portland, Oregon, USA.

出版信息

Bosn J Basic Med Sci. 2020 Aug 3;20(3):336-346. doi: 10.17305/bjbms.2020.4632.

DOI:10.17305/bjbms.2020.4632
PMID:32020844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7416176/
Abstract

The two most commonly used immunohistochemical markers for neuroendocrine cells and their tumors are chromogranin A (CgA) and synaptophysin (SPY). CgA is a marker for neuroendocrine secretory granules of four pancreatic hormones and gastrin while SPY is a marker for synaptic vesicles in neuroendocrine cells, which release classic neurotransmitters such as acetylcholine and others. CgA is involved in synthesis and secretion of peptide hormones through exocytosis while the function of SPY is elusive. Thirty-five pancreatic neuroendocrine tumors (Pan-NETs) were studied, consisting of 14 insulinomas, 8 gastrinomas, 2 glucagonomas, 6 pancreatic polypeptidomas and 5 non-functioning tumors, and were immunostained for four pancreatic hormones, gastrin, CgA, and SPY. Majority of Pan-NETs were less immunostained for the endocrine hormones and CgA than the normal pancreatic endocrine cells. CgA immunostaining mostly correlates with each hormone staining in non-β-cell tumors, while SPY immunostaining recognizes endocrine cells diffusely in the cytoplasm. CgA immunostaining is less in insulinomas than in non-β-cell tumors, and CgA immunostaining may distinguish CgA-weaker insulinomas from CgA-stronger non-β-cell tumors. CgA immunostaining may be used as an independent marker for biological aggressiveness in non-β-cell Pan-NETs. The serum CgA levels are higher in subjects harboring non-β-cell tumors than those harboring insulinomas, and the serum CgA elevates in parallel to the increasing metastatic tumor mass. Thus, CgA positive immunostaining in Pan-NETs correlates with the elevated serum levels of CgA for diagnosing CgA-positive non-β-cell Pan-NETs and the increasing serum CgA levels indicate increasing metastatic tumor mass.

摘要

两种最常用于神经内分泌细胞及其肿瘤的免疫组织化学标志物是嗜铬粒蛋白 A(CgA)和突触素(SPY)。CgA 是四种胰腺激素和胃泌素分泌颗粒的标志物,而 SPY 是神经内分泌细胞中突触小泡的标志物,这些细胞释放经典神经递质,如乙酰胆碱等。CgA 通过胞吐作用参与肽激素的合成和分泌,而 SPY 的功能尚不清楚。研究了 35 例胰腺神经内分泌肿瘤(Pan-NETs),包括 14 例胰岛素瘤、8 例胃泌素瘤、2 例胰高血糖素瘤、6 例胰多肽瘤和 5 例无功能肿瘤,并对四种胰腺激素、胃泌素、CgA 和 SPY 进行免疫染色。大多数 Pan-NETs 的内分泌激素和 CgA 免疫染色比正常胰腺内分泌细胞少。CgA 免疫染色与非-β 细胞肿瘤中每种激素染色大多相关,而 SPY 免疫染色则在细胞质中弥漫性识别内分泌细胞。胰岛素瘤中的 CgA 免疫染色比非-β 细胞肿瘤少,CgA 免疫染色可能将 CgA 较弱的胰岛素瘤与 CgA 较强的非-β 细胞肿瘤区分开来。CgA 免疫染色可作为非-β 细胞 Pan-NETs 生物学侵袭性的独立标志物。非-β 细胞肿瘤患者的血清 CgA 水平高于胰岛素瘤患者,并且血清 CgA 水平随转移性肿瘤质量的增加而平行升高。因此,Pan-NETs 中的 CgA 阳性免疫染色与升高的 CgA 血清水平相关,用于诊断 CgA 阳性非-β 细胞 Pan-NETs,而升高的血清 CgA 水平表明转移性肿瘤质量增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/d6ff919b2a50/BJBMS-20-336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/d7ec275cf66a/BJBMS-20-336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/543a82fc91e4/BJBMS-20-336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/d6ff919b2a50/BJBMS-20-336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/d7ec275cf66a/BJBMS-20-336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/543a82fc91e4/BJBMS-20-336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0c/7416176/d6ff919b2a50/BJBMS-20-336-g005.jpg

相似文献

1
Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors.嗜铬粒蛋白 A 和突触素在胰腺神经内分泌肿瘤中的意义。
Bosn J Basic Med Sci. 2020 Aug 3;20(3):336-346. doi: 10.17305/bjbms.2020.4632.
2
Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.降钙素和突触素在甲状腺髓样癌中的意义。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):535-541. doi: 10.17305/bjbms.2020.5407.
3
[Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].胰腺神经内分泌肿瘤的临床病理特征:64例回顾性分析
Zhonghua Zhong Liu Za Zhi. 2014 Apr;36(4):287-93.
4
Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.胰岛素瘤相关蛋白 1 在 FNA 涂片上对各种神经内分泌肿瘤的免疫染色。
Cancer Cytopathol. 2020 Oct;128(10):725-732. doi: 10.1002/cncy.22310. Epub 2020 Jun 23.
5
PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors.PGP9.5 免疫细胞化学染色用于胰腺内分泌肿瘤。
Islets. 2013 May-Jun;5(3):122-8. doi: 10.4161/isl.25351. Epub 2013 Jun 27.
6
Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population.嗜铬粒蛋白A:中国人群胰腺非胰岛素瘤神经内分泌肿瘤的一种有价值的血清诊断标志物
Med Sci Monit. 2020 Nov 3;26:e926635. doi: 10.12659/MSM.926635.
7
[The diagnostic value of plasma chromogranin A in neuroendocrine tumors].[血浆嗜铬粒蛋白A在神经内分泌肿瘤中的诊断价值]
Zhonghua Nei Ke Za Zhi. 2011 Feb;50(2):124-7.
8
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.P53、生长抑素受体 2a 和嗜铬粒蛋白 A 免疫染色作为高级胃肠胰神经内分泌肿瘤的预后标志物。
BMC Cancer. 2020 Jan 10;20(1):27. doi: 10.1186/s12885-019-6498-z.
9
Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.嗜铬粒蛋白A是胰腺神经内分泌肿瘤可靠的血清诊断生物标志物,但对胰岛素瘤并非如此。
BMC Endocr Disord. 2014 Aug 7;14:64. doi: 10.1186/1472-6823-14-64.
10
[Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].[胃肠道和胰腺神经内分泌肿瘤:一项临床病理及免疫组织化学研究]
Zhonghua Bing Li Xue Za Zhi. 2012 Oct;41(10):696-7. doi: 10.3760/cma.j.issn.0529-5807.2012.10.011.

引用本文的文献

1
Gallbladder Neuroendocrine Neoplasms in Dogs and Humans.犬类和人类的胆囊神经内分泌肿瘤
Vet Sci. 2024 Aug 12;11(8):371. doi: 10.3390/vetsci11080371.
2
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms.神经内分泌胰腺肿瘤对链脲佐菌素反应的预测因素
J Clin Med. 2023 Dec 7;12(24):7557. doi: 10.3390/jcm12247557.
3
Insulinoma in Patient With Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎患者的胰岛素瘤

本文引用的文献

1
Chromogranin A as a valid marker in oncology: Clinical application or false hopes?嗜铬粒蛋白A作为肿瘤学中的有效标志物:临床应用还是虚幻希望?
World J Methodol. 2017 Mar 26;7(1):9-15. doi: 10.5662/wjm.v7.i1.9.
2
Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls.嗜铬粒蛋白A——非特异性神经内分泌标志物。临床应用及潜在诊断陷阱。
Arch Med Sci. 2016 Feb 1;12(1):1-9. doi: 10.5114/aoms.2016.57577. Epub 2016 Feb 2.
3
Architecture of the Synaptophysin/Synaptobrevin Complex: Structural Evidence for an Entropic Clustering Function at the Synapse.
Cureus. 2023 Aug 14;15(8):e43469. doi: 10.7759/cureus.43469. eCollection 2023 Aug.
4
Al[F]F-NOTA-Octreotide Is Comparable to [Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population.Al[F]F-NOTA-奥曲肽在拉丁美洲人群神经内分泌肿瘤的PET/CT成像中与[Ga]Ga-DOTA-泰曲肽相当。
Cancers (Basel). 2023 Jan 10;15(2):439. doi: 10.3390/cancers15020439.
5
Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.干细胞分化为胰岛素分泌细胞(IPCs):最新进展和当前挑战。
Stem Cell Res Ther. 2022 Jul 15;13(1):309. doi: 10.1186/s13287-022-02977-y.
6
Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer.SV2A 靶向 PET 成像用于前列腺癌神经内分泌分化的无创评估的验证。
Int J Mol Sci. 2021 Dec 3;22(23):13085. doi: 10.3390/ijms222313085.
7
Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.降钙素和突触素在甲状腺髓样癌中的意义。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):535-541. doi: 10.17305/bjbms.2020.5407.
8
Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population.嗜铬粒蛋白A:中国人群胰腺非胰岛素瘤神经内分泌肿瘤的一种有价值的血清诊断标志物
Med Sci Monit. 2020 Nov 3;26:e926635. doi: 10.12659/MSM.926635.
突触素/突触囊泡蛋白复合物的结构:突触处熵聚集功能的结构证据。
Sci Rep. 2015 Sep 3;5:13659. doi: 10.1038/srep13659.
4
Neuroendocrine tumors of the luminal gastrointestinal tract.腔内胃肠道神经内分泌肿瘤
Arch Pathol Lab Med. 2015 Jun;139(6):750-6. doi: 10.5858/arpa.2014-0130-RA.
5
Chromogranin A as a marker for diagnosis, treatment, and survival in patients with gastroenteropancreatic neuroendocrine neoplasm.嗜铬粒蛋白A作为胃肠胰神经内分泌肿瘤患者诊断、治疗及生存情况的标志物
Medicine (Baltimore). 2014 Dec;93(27):e247. doi: 10.1097/MD.0000000000000247.
6
Biological function and clinical relevance of chromogranin A and derived peptides.嗜铬粒蛋白 A 及其衍生肽的生物学功能及临床意义。
Endocr Connect. 2014 Apr 29;3(2):R45-54. doi: 10.1530/EC-14-0027. Print 2014.
7
Synaptic vesicle recycling: steps and principles.突触囊泡循环:步骤和原理。
EMBO J. 2014 Apr 16;33(8):788-822. doi: 10.1002/embj.201386357. Epub 2014 Mar 3.
8
Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.胰腺神经内分泌肿瘤:临床特征、诊断和治疗:进展。
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):737-53. doi: 10.1016/j.bpg.2012.12.003.
9
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?在胃肠胰神经内分泌肿瘤的诊断和随访中,联合检测嗜铬粒蛋白 A 和胰多肽血清是否有意义?
Eur J Cancer. 2012 Aug;48(12):1766-73. doi: 10.1016/j.ejca.2011.11.005. Epub 2011 Nov 29.
10
The extended granin family: structure, function, and biomedical implications.延伸的颗粒家族:结构、功能和生物医学意义。
Endocr Rev. 2011 Dec;32(6):755-97. doi: 10.1210/er.2010-0027. Epub 2011 Aug 23.